Opendata, web and dolomites

PRECODE SIGNED

PancREatic Cancer OrganoiDs rEsearch Network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PRECODE project word cloud

Explore the words cloud of the PRECODE project. It provides you a very rough idea of what is the project "PRECODE" about.

connect    generation    innovation    experiments    terrible    capacitation    shared    fulfils    patient    clinical    italy    learning    consists    material    advocate    3r    innovative    medicine    biology    organoid    drugs    international    small    training    techniques    recapitulate    establishing    firmly    throughput    intersectorial    mission    vitro    cultivate    drug    competences    organization    goes    manipulate    metabolomics    doctorate    cutting    union    sources    career    train    time    technologies    variety    workshops    fit    central    goals    glove    earn    animal    education    combination    organoids    organs    perfect    precode    excellence    beneficiaries    deduct    precision    molecular    investigation    isolated    network    group    disease    pancreatic    interdisciplinary    reduce    cancer    minimal    esrs    sweden    thereof    secondments    viewed    function    15    tool    sequencing    creative    groups    edge    therapy    germany    micro    professional   

Project "PRECODE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITATSKLINIKUM ERLANGEN 

Organization address
address: MAXIMILIANSPLATZ 2
city: ERLANGEN
postcode: 91054
website: www.uk-erlangen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 3˙992˙891 €
 EC max contribution 3˙992˙891 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2023-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITATSKLINIKUM ERLANGEN DE (ERLANGEN) coordinator 252˙788.00
2    ASTRAZENECA UK LIMITED UK (CAMBRIDGE) participant 303˙172.00
3    UNIVERSITY OF GLASGOW UK (GLASGOW) participant 303˙172.00
4    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 281˙982.00
5    UMEA UNIVERSITET SE (UMEA) participant 281˙982.00
6    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 274˙684.00
7    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 265˙619.00
8    MIMETAS BV NL (Leiden) participant 265˙619.00
9    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 265˙619.00
10    UNIVERSITA DEGLI STUDI DI VERONA IT (VERONA) participant 261˙499.00
11    CELLPHENOMICS GMBH DE (BERLIN) participant 252˙788.00
12    FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN NUERNBERG DE (ERLANGEN) participant 252˙788.00
13    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) participant 252˙788.00
14    UNIVERSIDAD DE NAVARRA ES (PAMPLONA) participant 250˙904.00
15    GDANSKI UNIWERSYTET MEDYCZNY PL (GDANSK) participant 227˙478.00

Map

 Project objective

The PRECODE Network (PancREatic Cancer OrganoiDs rEsearch) central mission is to establish pancreatic organoid research firmly in the European Union, by training the next generation of creative and innovative researchers in pancreatic cancer. This will be done through a shared doctorate program of excellence that fulfils the three “I”: international, interdisciplinary and intersectorial. Organoids can be viewed as small micro-organs which can recapitulate the organization and the function thereof. As micro-organs organoids can be used to reduce animal experiments and help to reach 3R goals. Organoids from pancreatic cancer will help us to learn which drugs might help in the therapy of this terrible disease. They can be isolated from a variety of clinical sources with minimal material needed. This makes them a perfect tool for precision medicine. Sequencing, metabolomics and high throughput in vitro experiments to deduct the best possible drug combination fit hand in glove with this approach. Training of ESRs will be achieved by e-learning, workshops and secondments. They will earn to cultivate and manipulate organoids as well as cutting edge molecular biology techniques. Therefore our work group consists of 15 beneficiaries and 7 partner organization (including three patient advocate groups from Sweden, Italy and Germany) to develop those technologies and to train ESRs in their application. PRECODE will therefore connect the concepts of investigation, education and innovation establishing a capacitation for the ESRs that goes beyond the state of the art and that will allow them to improve their competences and their professional career at the same time that we advance towards innovation in the field of pancreatic cancer research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRECODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PRECODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More